The
report covers the analysis and forecast of the global
human microbiome market on global as well as regional level. The
study provides historic data of 2016 along with the forecast for the period
between 2017 and 2025 based on revenue (USD Million).
The
study provides a detailed view of the global human microbiome market, by
segmenting it based on diseases, technology, product, end-use and geographical
boundaries. The disease segment includes cancer, diabetes, obesity, acute
diarrhea or metabolic disorders, autoimmune disorders, mental disorders, atopic
dermatitis and other diseases. Based on technology, the global human microbiome
market can be segmented into cell culture technology, omics technology,
high-throughput technology and computational tools. On the other hand, product
wise, the market has been bifurcated into consumables and instruments. By
end-use, the global human microbiome market has been classified into
prebiotics, probiotics, other probiotic supplements, foods, medical foods,
drugs and diagnostic services.
Regional
segmentation includes the current and forecast demand for North America,
Europe, Asia Pacific, Middle East and Africa, and Latin America. Market
dynamics for each region has been provided in the report.
The
competitive profiling of the key players in the global human microbiome
market across five broad geographic regions is included in the study. These
include different business strategies adopted by the leading players and their
recent developments, as in the field of global human microbiome market.
A
comprehensive analysis of the market dynamics that is inclusive of market
drivers, restraints, and opportunities is part of the report. Additionally, the
report includes potential opportunities in the global human microbiome market
at the global and regional levels. Market dynamics are the factors which impact
the market growth, so their analysis helps understand the ongoing trends of the
global market. Therefore, the report provides the forecast of the global market
for the period from 2017 to 2025, along with offering an inclusive study of the
global human microbiome market.
The
report provides the size of the global human microbiome market from 2016 and
the forecast for the next eight years up to 2025. The size of the global human
microbiome market is provided in terms of revenue. Market revenue is defined in
USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific,
Middle East and Africa, and Latin America have been considered in estimating
the growth of the global market.
The
market estimates for this study have been based on revenue being derived
through regional pricing trends. Demand for global human microbiome has
been derived by analyzing the global and regional demand for each segment for
its respective functions. Forecasts have been based on expected demand from the
specific product types and their utilization. We have used the bottom-up
approach to estimate the global revenue of the global human microbiome market,
split into regions. Based on disease types and product types, individual
revenues have been summed up from all the regions to achieve the global revenue
for the market. Various companies were considered for the market share
analysis, based on their innovation, application and revenue generation. In the
absence of specific data related to the sales of human microbiome by privately
held companies; calculated assumptions have been made in view of the company's
penetration and regional presence across product and end-use segments.
The
report covers a detailed competitive outlook that includes the market share and
company profiles of key players operating in the global human microbiome
market. Key players profiled in the report include ActoGeniX, AvidBiotics,
DuPont, Enterome Bioscience, Metabiomics Corporation, Merck and Co., MicroBiome
Therapeutics LLC, Optibiotix Health PLC, Osel, Ritter Pharmaceuticals, Inc.,
Seres Therapeutics, Second Genome, Inc., Vedanta BioSciences, ViThera
Pharmaceuticals and Yakult Honsha Co., Ltd. among others.
The global human microbiome
market has been segmented into:
Global Human Microbiome
Market: By Diseases
Cancer
Diabetes
Obesity
Acute
Diarrhea or Metabolic Disorders
Autoimmune
Disorders
Mental
Disorders
Atopic
Dermatitis and
Other
Diseases
Global Human Microbiome
Market: By Technology
Cell
Culture Technology
Omics
Technology
High-Throughput
Technology
Computational
Tools
Global Human Microbiome
Market: By Product
Consumables
Instruments
Global Human Microbiome
Market: By End-Use
Prebiotics
Probiotics
Other
Probiotic Supplements
Foods
Medicated
Foods
Drugs
and
Diagnostic
services
Global Human Microbiome
Market: By Geography
North
America
U.S.
Canada
Mexico
Europe
U.K.
Italy
France
Germany
Russia
Spain
Rest
of Europe
Asia
Pacific
India
China
Japan
Australia
Rest
of Asia Pacific
Middle
East and Africa
GCC
South
Africa
Rest
of Middle East and Africa
Latin
America
Brazil
Rest
of Latin America
For More Information on the research report,
refer to below link:-
Related Report:-
Contact
Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
No comments:
Post a Comment